baricitinib

• Health

Risk profile tool provides clearer insight on hospitalized COVID-19 patients who benefit most from baricitinib treatment

Credit: CC0 Public Domain A post-hoc analysis of ACTT-2 (Adaptive COVID-19 Treatment Trial-2) found that the use of a risk…